Despite its status as the “pharmacy of the world,” India’s deep life sciences roots have traditionally been based in manufacturing and replication. | A string of recent wins on the frontiers of novel drug development could mean that a homegrown innovation industry is within reach.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
India pharma sector moves beyond generics to biosimilars, biologics and AI-driven manufacturing, strengthening exports and global…
India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars,…
While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and…
India's biotech sector is evolving towards innovation, yet funding challenges hinder the growth of competitive global companies.
This article is authored by Vedha Sampathkumar, partner, Endiya Partners.
Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new…
